BOTANICAL EFFICACY STUDIES: "NEEDLESS IMPEDIMENTS" SHOULD BE REMOVED
This article was originally published in The Tan Sheet
Executive Summary
BOTANICAL EFFICACY STUDIES: "NEEDLESS IMPEDIMENTS" SHOULD BE REMOVED, FDA Office of Drug Evaluation I Director Robert Temple, MD, told a Dec. 14-16 conference on botanicals sponsored by FDA and the Office of Alternative Medicine. "What I want FDA to do is put no needless impediments in the way of doing those trials," Temple said. "We are now seeing a small kernel of people who actually want to do controlled trials...and I'd be upset if we were doing anything to discourage that."